Edward Hook is an Infectious Disease physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1717 6th Ave S
Birmingham, AL 352331801
Telephone
800-822-8816Registry record last updated 1 Jun 2023.
Clinical trials
- Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea
Sponsor: Melinta Therapeutics, Inc.
- HIV Prevention in the Primary Care Setting
Sponsor: University of Alabama at Birmingham
- Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections
Sponsor: Centers for Disease Control and Prevention
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Visby Medical, Inc.Program year20254 payments$15,000openpaymentsdata.cms.gov ↗
- Visby Medical, Inc.Program year20244 payments$15,000openpaymentsdata.cms.gov ↗
- La Jolla Pharmaceutical CompanyProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
13 NIH research awards on record, funded 1995–2025 per NIH RePORTER. The latest:
- Task 12: Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae
University of Alabama at Birmingham
FY2025$1,046,990272201300012I - Task 12: Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae
University of Alabama at Birmingham
FY2024$848,444272201300012I - Sexually Transmitted Infections Clinical Trials Group: Phase III Clinical Trial for Syphilis Therapeutics
University of Alabama at Birmingham
FY2020$1,339,905272201300012I
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”